Details of the Drug

General Information of Drug (ID: DMCJI5P)

Drug Name

N-1177-inh

Synonyms

N-1177; PH-50; WIN-67722; Imaging agent (cancer), IMCOR; Imaging agent (cancer), Photogen; Imaging agent (cardiovascular), IMCOR; Imaging agent (cardiovascular), Photogen; N-1177-iv; N-1177-sq; N-1177-sq); Nanoparticle contrast agent (atherosclerosis), NanoScan Imaging; Nanoparticle contrast agent (cancer), NanoScan Imaging; Nanoparticle contrast agent (pulmonary tumor), NanoScan Imaging; N-1177 (inhaled, lung cancer), NanoScan Imaging; N-1177 (intravenous,atherosclerosis), NanoScan Imaging; N-1177 (subcutaneous,cancer), NanoScan Imaging

Indication

Disease Entry	ICD 11	Status	REF
Lymphoma	2A80-2A86	Discontinued in Phase 1	[1]

Structure

3D Structure is Not Available

3D MOL

2D MOL

Cross-matching ID

TTD ID: D0I4FL

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015744)